JournalTOCs

Expert Opinion on Therapeutic Patents
Journal Prestige (SJR): 0.926

Citation Impact (citeScore): 3
Number of Followers: 9

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1354-3776 - ISSN (Online) 1744-7674
Published by Taylor and Francis

[2648 journals]

P2X receptor antagonists and their potential as therapeutics: a patent
review (2010–2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Chianna Dane, Leanne Stokes, William T Jorgensen
  Pages: 1 - 22
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-05-11T01:09:40Z
  DOI: 10.1080/13543776.2022.2069010
Carbon-11 patents (2012–2022): synthetic methodologies and novel
radiotracers for PET imaging
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sridhar Goud Nerella, Priti Singh, Sanam Tulja
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-28T07:49:34Z
  DOI: 10.1080/13543776.2022.2070003
Anti-viral activity of thiazole derivatives: an updated patent review
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Thoraya A. Farghaly, Amani M. R. Alsaedi, Noof A. Alenazi, Marwa F. Harras
  Pages: 1 - 25
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-27T07:00:49Z
  DOI: 10.1080/13543776.2022.2067477
ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting
perspective
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Carlotta Granchi
  Pages: 1 - 12
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-25T06:20:59Z
  DOI: 10.1080/13543776.2022.2067478
Soluble epoxide hydrolase inhibitors: an overview and patent review from
the last decade
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Malliga R. Iyer, Biswajit Kundu, Casey M. Wood
  Pages: 1 - 19
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-12T07:47:43Z
  DOI: 10.1080/13543776.2022.2054329
Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and
NPP2/ ATX as important drug targets: A patent review (2015-2020)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sehrish Bano, Mariya Al-Rashida, Rima D Alharthy, Imtiaz Ali Khan, Jamshed Iqbal
  Pages: 1 - 9
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-12T07:01:29Z
  DOI: 10.1080/13543776.2022.2058874
A patent review of adenosine A2B receptor antagonists (2016-present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Beatrice Francucci, Diego Dal Ben, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini, Gabriella Marucci, Michela Buccioni
  Pages: 1 - 24
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-07T07:40:57Z
  DOI: 10.1080/13543776.2022.2057222
The intriguing role of USP30 inhibitors as deubiquitinating enzymes from
the patent literature since 2013
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sofia Ferrer, Michael E. Muratore, Peter Buijnsters
  Pages: 1 - 37
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-04T08:19:16Z
  DOI: 10.1080/13543776.2022.2003780
An updated patent review of small-molecule ROS1 kinase inhibitors
(2015–2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Meng Liu, Jintian Dai, Mudan Wei, Qingshan Pan, Wufu Zhu
  Pages: 1 - 17
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-01T07:48:43Z
  DOI: 10.1080/13543776.2022.2058872
Novel inhibitors of the STAT3 signaling pathway: an updated patent review
(2014-present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Feng Wang, Xin-Yu Cao, Guo-Qiang Lin, Ping Tian, Dingding Gao
  Pages: 1 - 22
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-01T07:44:36Z
  DOI: 10.1080/13543776.2022.2056013
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors
(2014-present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Peng Li, Ying Liu, Hong-Min Liu
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-31T12:21:15Z
  DOI: 10.1080/13543776.2022.2058873
Dopamine D3 receptor ligands: a patent review (2014–2020)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Rita Maria Concetta Di Martino, Andrea Cavalli, Giovanni Bottegoni
  Pages: 1 - 23
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-24T07:06:51Z
  DOI: 10.1080/13543776.2022.2049240
Malaria transmission blocking compounds: a patent review
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sara Consalvi, Chiara Tammaro, Federico Appetecchia, Mariangela Biava, Giovanna Poce
  Pages: 1 - 18
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-11T12:48:44Z
  DOI: 10.1080/13543776.2022.2049239
Small molecules as kinetoplastid specific proteasome inhibitors for
leishmaniasis: a patent review from 1998 to 2021
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Mohd Imran, Shah Alam Khan, Abida, Ahmed Subeh Alshrari, Mahmoud Mudawi Eltahir Mudawi, Mohammed Kanan Alshammari, Aishah Ali Harshan, Noufah Aqeel Alshammari
  Pages: 1 - 14
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-11T08:04:45Z
  DOI: 10.1080/13543776.2022.2045948
Menin-MLL protein-protein interaction inhibitors: a patent review
(2014–2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Huanrong Bai, San-Qi Zhang, Hao Lei, Fang Wang, Mengyan Ma, Minhang Xin
  Pages: 1 - 16
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-11T08:02:41Z
  DOI: 10.1080/13543776.2022.2045947
Small Molecule Inhibitors of Programmed Cell Death Ligand 1 (PD-L1): A
Patent Review (2019–2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Jingjing Deng, Zhengqi Cheng, Juyang Long, Alexander Dömling, Micky Tortorella, Yuanze Wang
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-11T07:58:50Z
  DOI: 10.1080/13543776.2022.2045276
A patent review on cathepsin K inhibitors to treat osteoporosis (2011
– 2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Fernanda R. Rocho, Vinícius Bonatto, Rafael F. Lameiro, Jerônimo Lameira, Andrei Leitão, Carlos A. Montanari
  Pages: 1 - 13
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-10T04:15:45Z
  DOI: 10.1080/13543776.2022.2040480
Inhibitors of the GTPase KRASG12C in cancer: a patent review (2019-2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Qifu Xu, Guozhen Zhang, Qian Liu, Shunda Li, Yingjie Zhang
  Pages: 1 - 31
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-02-22T05:17:53Z
  DOI: 10.1080/13543776.2022.2032648